Hello, everyone. Nice to see you again. We were on the road part of yesterday, so resuming the usual routine is always welcome. And, of course, there is much to do. We all face meetings and deadlines, after all. To get started, we are brewing our mandatory cup of stimulation and looking forward to a day of accomplishments. We hope you achieve your own goals today. To help you along, here are a few items of interest. Stay in touch...
Regeneron Shares Jump After CEO Touts Drugs (Reuters)
FDA Panel Mostly Backs Controversial Knee Device (Associated Press)
Sanofi-Aventis Antiplatelet Drug Gets EC Approval (MarketWatch)
Novartis Gives Voltaren Emulgel Account To Starcom In China (MediaAsia)
Glaxo And Pfizer Agree To Supply Pneumonia Vaccines (Associated Press)
Perrigo Buys Infant Formula Maker (Richmond Times-Dispatch)